Th17 T cells: Linking innate and adaptive immunity

Seminars in Immunology

Volumn 19, Issue 6, 2007, Pages 353-361

  Stockinger, Brigitta ^a   Veldhoen, Marc ^a   Martin, Bruno ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Adaptive immunity; Autoimmunity; Cytokines; Innate immunity; T cell differentiation; TGF ; Th17

Indexed keywords

INTERLEUKIN 17;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; HELPER CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL;

ANIMALS; AUTOIMMUNITY; CYTOKINES; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-17; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 39449128293     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.10.008     Document Type: Review

References (104)

1. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3 6 (1995) 811-821
2. Kennedy J., Rossi D.L., Zurawski S.M., Vega Jr. F., Kastelein R.A., Wagner J.L., et al. Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J Interferon Cytokine Res 16 8 (1996) 611-617
3. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 11 (2005) 1123-1132
4. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 2 (2006) 179-189
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 7090 (2006) 235-238
6. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 7090 (2006) 231-234
7. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 6 (2006) 1121-1133
8. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282 13 (2007) 9358-9363
9. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178 8 (2007) 4901-4907
10. Nishihara M., Ogura H., Ueda N., Tsuruoka M., Kitabayashi C., Tsuji F., et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 19 (2007) 695-702
11. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 103 21 (2006) 8137-8142
12. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 7152 (2007) 484-487
13. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 7152 (2007) 480-483
14. Zhou L., Ivanov I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs Th-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007) 967-974
15. Matsuki T., Nakae S., Sudo K., Horai R., and Iwakura Y. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 18 2 (2006) 399-407
16. Sutton C., Brereton C., Keogh B., Mills K.H., and Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203 7 (2006) 1685-1691
17. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 3 (2007) 371-381
18. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
19. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing helper memory cells. Nat Immunol 8 (2007) 639-646
20. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7 11 (2006) 1151-1156
21. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204 1 (2007) 41-47
22. Li M.O., Wan Y.Y., and Flavell R.A. T cell-produced transforming growth factor-β1controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity (2007) 26
23. Gandhi R., Anderson D.E., and Weiner H.L. Cutting edge: immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner. J Immunol 178 7 (2007) 4017-4021
24. Infante-Duarte C., Horton H.F., Byrne M.C., and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165 11 (2000) 6107-6115
25. Huang W., Na L., Fidel P.L., and Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190 3 (2004) 624-631
26. Du Z., Kelly E., Mecklenbrauker I., Agle L., Herrero C., Paik P., et al. Selective regulation of IL-10 signaling and function by zymosan. J Immunol 176 8 (2006) 4785-4792
27. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116 4 (2006) 916-928
28. Siciliano N.A., Skinner J.A., and Yuk M.H. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177 10 (2006) 7131-7138
29. Fossiez F., Banchereau J., Murray R., Van Kooten C., Garrone P., and Lebecque S. Interleukin-17. Int Rev Immunol 16 5/6 (1998) 541-551
30. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8 4 (2007) 369-377
31. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201 6 (2005) 949-960
32. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8 1 (2007) 31-38
33. Leibundgut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8 (2007) 630-638
34. Fritz J.H., Le Bourhis L., Sellge G., Magalhaes J.G., Fsihi H., Kufer T.A., et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26 (2007) 445-459
35. Lockhart E., Green A.M., and Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 7 (2006) 4662-4669
36. Shibata K., Yamada H., Hara H., Kishihara K., and Yoshikai Y. Resident V{delta}1+ {gamma}{delta} T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178 7 (2007) 4466-4472
37. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J Exp Med 204 (2007) 995-1001
38. Ferretti S., Bonneau O., Dubois G.R., Jones C.E., and Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170 4 (2003) 2106-2112
39. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 11 (2006) 2473-2483
40. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116 5 (2006) 1310-1316
41. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203 11 (2006) 2485-2494
42. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25 2 (2006) 309-318
43. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 6 (2006) 677-688
44. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
45. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194 5 (2001) 629-644
46. Powrie F., Carlino J., Leach M.W., Mauze S., and Coffman R.L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183 6 (1996) 2669-2674
47. Veldhoen M., Moncrieffe H., Hocking R.J., Atkins C.J., and Stockinger B. Modulation of dendritic cell function by naive and regulatory CD4+ T cells. J Immunol 176 10 (2006) 6202-6210
48. Xu L., Kitani A., Fuss I., and Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178 11 (2007) 6725-6729
49. Luo X., Tarbell K.V., Yang H., Pothoven K., Bailey S.L., Ding R., et al. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 104 8 (2007) 2821-2826
50. Tarbell K.V., Petit L., Zuo X., Toy P., Luo X., Mqadmi A., et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204 1 (2007) 191-201
51. Sun C.-M., Hall J., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg via retinoid acid. J Exp Med 204 (2007) 1775-1785
52. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204 8 (2007) 1757-1764
53. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 5835 (2007) 256-260
54. Fahlen L., Read S., Gorelik L., Hurst S.D., Coffman R.L., Flavell R.A., et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 201 (2005) 737-746
55. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 11 (2005) 1142-1151
56. Setoguchi R., Hori S., Takahashi T., and Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201 5 (2005) 723-735
57. Barthlott T., Moncrieffe H., Veldhoen M., Atkins C.J., Christensen J., O'Garra A., et al. CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 17 3 (2005) 279-288
58. de la Rosa M., Rutz S., Dorninger H., and Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34 9 (2004) 2480-2488
59. Lohr J., Knoechel B., Wang J.J., Villarino A.V., and Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203 13 (2006) 2785-2791
60. Dumoutier L., Van Roost E., Ameye G., Michaux L., and Renauld J.C. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1 8 (2000) 488-494
61. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 10 (2006) 2271-2279
62. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., and Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10 3 (1998) 259-264
63. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 7128 (2007) 648-651
64. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., Esterova E., Dickensheets H., Donnelly R.P., et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 166 12 (2001) 7096-7103
65. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 2 (2004) 241-254
66. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174 6 (2005) 3695-3702
67. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36 5 (2006) 1309-1323
68. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290 4 (2006) G827-G838
69. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 3 (2005) 969-984
70. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 5804 (2006) 1461-1463
71. Chang H., Hanawa H., Liu H., Yoshida T., Hayashi M., Watanabe R., et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 177 6 (2006) 3635-3643
72. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 5 (2004) 1332-1342
73. Pan H., Hong F., Radaeva S., and Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 1 1 (2004) 43-49
74. El Kasmi K.C., Holst J., Coffre M., Mielke L., de Pauw A., Lhocine N., et al. General nature of the STAT3-activated anti-inflammatory response. J Immunol 177 11 (2006) 7880-7888
75. Wolk K., Witte E., Hoffmann U., Doecke W.D., Endesfelder S., Asadullah K., et al. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol 178 9 (2007) 5973-5981
76. Bettelli E., Sullivan B., Szabo S.J., Sobel R.A., Glimcher L.H., and Kuchroo V.K. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 200 1 (2004) 79-87
77. Lugo-Villarino G., Ito S., Klinman D.M., and Glimcher L.H. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc Natl Acad Sci USA 102 37 (2005) 13248-13253
78. Wang J., Fathman J.W., Lugo-Villarino G., Scimone L., von Andrian U., Dorfman D.M., et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J Clin Invest 116 2 (2006) 414-421
79. Gocke A.R., Cravens P.D., Ben L.H., Hussain R.Z., Northrop S.C., Racke M.K., et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol 178 3 (2007) 1341-1348
80. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237 2 (2005) 123-130
81. Rangachari M., Mauermann N., Marty R.R., Dirnhofer S., Kurrer M.O., Komnenovic V., et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203 8 (2006) 2009-2019
82. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19 (2007) 1-6
83. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25 (2007) 221-242
84. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 1 (2006) 17-23
85. Kikly K., Liu L., Na S., and Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18 6 (2006) 670-675
86. Bowman E.P., Chackerian A.A., and Cua D.J. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Curr Opin Infect Dis 19 3 (2006) 245-252
87. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4 6 (2003) 540-545
88. Gutcher I., Urich E., Wolter K., Prinz M., and Becher B. Interleukin 18-dependent engagement of interleukin 18 receptor-a is required for autoimmune inflammation. Nat Immunol 7 (2006) 946-953
89. Khader S.A., Partida-Sanchez S., Bell G., Jelley-Gibbs D.M., Swain S., Pearl J.E., et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 203 7 (2006) 1805-1815
90. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13 4 (2007) 423-431
91. Bailey S.L., Schreiner B., McMahon E.J., and Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4(+) T(H)-17 cells in relapsing EAE. Nat Immunol 8 2 (2007) 172-180
92. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200 3 (2004) 277-285
93. van Amelsfort J.M., van Roon J.A., Noordegraaf M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., et al. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56 3 (2007) 732-742
94. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 9 (2006) 937-945
95. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 9 (2006) 929-936
96. Veldhoen M., and Stockinger B. TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells. Trends Immunol 27 8 (2006) 358-361
97. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175 2 (2005) 788-795
98. Visser L., Jan de Heer H., Boven L.A., van Riel D., van Meurs M., Melief M.J., et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 174 2 (2005) 808-816
99. Schrijver I.A., van Meurs M., Melief M.J., Wim Ang C., Buljevac D., Ravid R., et al. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 124 Pt 8 (2001) 1544-1554
100. Chen X., Howard O.M., and Oppenheim J.J. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 178 10 (2007) 6123-6129
101. Oertelt S., Lian Z.X., Cheng C.M., Chuang Y.H., Padgett K.A., He X.S., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 177 3 (2006) 1655-1660
102. Gorelik L., and Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181
103. Marie J.C., Liggitt D., and Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25 3 (2006) 441-454
104. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146